Pay in 4 interest-free payments of $7.34 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
For those who are already using weight loss medication, Wegovy's availability is highly anticipated to decrease their weight further with fewer side effects
These hemodynamic interactions are not reflected in current prescribing information for tirzepatide, not because they have been evaluated and found absent, but because patients with hEDS and POTS were not systematically enrolled in the pivotal SURMOUNT trials, which excluded individuals with significant cardiovascular, renal, and neurological comorbidities
What things have they already tried
Post-hoc analyses from clinical trials show tirzepatide may reduce high-sensitivity C-reactive protein (hsCRP) levels, though reductions appear to correlate with weight loss and improved glycemic control
2013 Aug;10(2):203-10
